These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9934459)

  • 21. Quantitative structure-activity relationship (QSAR) analysis of a series of indole analogues as inhibitor for human group V secretory phospholipase A2.
    OmPraba G; Velmurugan D
    Indian J Biochem Biophys; 2006 Jun; 43(3):154-9. PubMed ID: 16967904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of enzyme-inhibitory phospholipid analogs. III. A facile synthesis of N-acylaminoethylphosphorylcholines.
    Chandrakumar NS; Boyd VL; Hajdu J
    Biochim Biophys Acta; 1982 May; 711(2):357-60. PubMed ID: 7093303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The identification of a potent, water soluble inhibitor of lipoprotein-associated phospholipase A2.
    Boyd HF; Hammond B; Hickey DM; Ife RJ; Leach CA; Lewis VA; Macphee CH; Milliner KJ; Pinto IL; Smith SA; Stansfield IG; Theobald CJ; Whittaker CM
    Bioorg Med Chem Lett; 2001 Mar; 11(5):701-4. PubMed ID: 11266173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding mode of phospholipase A2 with a new type of phospholipid analog having an oxazolidinone ring.
    Tani T; Fujii S; Inoue S; Ikeda K; Iwama S; Matsuda T; Katsumura S; Samejima Y; Hayashi K
    J Biochem; 1995 Jan; 117(1):176-82. PubMed ID: 7775386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and synthesis of 1-indol-1-yl-propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha.
    Ludwig J; Bovens S; Brauch C; Elfringhoff AS; Lehr M
    J Med Chem; 2006 Apr; 49(8):2611-20. PubMed ID: 16610804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An affinity column for phospholipase A2 based on immobilised acylaminophospholipid analogues.
    Dijkman R; Beiboer SH; Verheij HM
    Biochim Biophys Acta; 1997 Jul; 1347(1):1-8. PubMed ID: 9233682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural product derived inhibitors of lipoprotein associated phospholipase A2, synthesis and activity of analogues of SB-253514.
    Pinto IL; Boyd HF; Hickey DM
    Bioorg Med Chem Lett; 2000 Sep; 10(17):2015-7. PubMed ID: 10987439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyrrolidine inhibitors of human cytosolic phospholipase A2. Part 2: synthesis of potent and crystallized 4-triphenylmethylthio derivative 'pyrrophenone'.
    Seno K; Okuno T; Nishi K; Murakami Y; Yamada K; Nakamoto S; Ono T
    Bioorg Med Chem Lett; 2001 Feb; 11(4):587-90. PubMed ID: 11229777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of specific peptide inhibitors for group I phospholipase A2: structure of a complex formed between phospholipase A2 from Naja naja sagittifera (group I) and a designed peptide inhibitor Val-Ala-Phe-Arg-Ser (VAFRS) at 1.9 A resolution reveals unique features.
    Singh RK; Vikram P; Makker J; Jabeen T; Sharma S; Dey S; Kaur P; Srinivasan A; Singh TP
    Biochemistry; 2003 Oct; 42(40):11701-6. PubMed ID: 14529280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phospholipase A2 inhibition at different substrate concentrations.
    Böhl M; Ketscher L; Tietböhl C; Gutzeit HO
    Anal Biochem; 2006 Dec; 359(2):280-2. PubMed ID: 17045950
    [No Abstract]   [Full Text] [Related]  

  • 31. Competitive inhibition of lipolytic enzymes. V. A monolayer study using enantiomeric acylamino analogues of phospholipids as potent competitive inhibitors of porcine pancreatic phospholipase A2.
    Ransac S; Deveer AM; Rivière C; Slotboom AJ; Gancet C; Verger R; De Haas GH
    Biochim Biophys Acta; 1992 Jan; 1123(1):92-100. PubMed ID: 1730050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total syntheses of (+)- and (-)-cacospongionolide B, cacospongionolide e, and related analogues. Preliminary study of structural features required for phospholipase a2 inhibition.
    Cheung AK; Murelli R; Snapper ML
    J Org Chem; 2004 Aug; 69(17):5712-9. PubMed ID: 15307744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of trimethoxyphenyl isoxazolidines as inhibitors of secretory phospholipase A2 with anti-inflammatory activity.
    Sadashiva MP; Nataraju A; Mallesha H; Rajesh R; Vishwanath BS; Rangappa KS
    Int J Mol Med; 2005 Nov; 16(5):895-904. PubMed ID: 16211261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A specific inhibitor of cytosolic phospholipase A2 activity, AACOCF3, inhibits glucose-induced insulin secretion from isolated rat islets.
    Loweth AC; Scarpello JH; Morgan NG
    Biochem Biophys Res Commun; 1996 Jan; 218(2):423-7. PubMed ID: 8561771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel 2-oxoamide inhibitors of human group IVA phospholipase A(2).
    Kokotos G; Kotsovolou S; Six DA; Constantinou-Kokotou V; Beltzner CC; Dennis EA
    J Med Chem; 2002 Jul; 45(14):2891-3. PubMed ID: 12086476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of lipidic amino acid and dipeptide inhibitors of human platelet phospholipase A2.
    Kokotos G; Constantinou-Kokotou V; Noula C; Nicolaou A; Gibbons WA
    Int J Pept Protein Res; 1996 Aug; 48(2):160-6. PubMed ID: 8872534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2.
    Boyd HF; Fell SC; Flynn ST; Hickey DM; Ife RJ; Leach CA; Macphee CH; Milliner KJ; Moores KE; Pinto IL; Porter RA; Rawlings DA; Smith SA; Stansfield IG; Tew DG; Theobald CJ; Whittaker CM
    Bioorg Med Chem Lett; 2000 Nov; 10(22):2557-61. PubMed ID: 11086729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phospholipid degradation in rat calcium ionophore-activated platelets is catalyzed mainly by two discrete secretory phospholipase As.
    Yokoyama K; Kudo I; Inoue K
    J Biochem; 1995 Jun; 117(6):1280-7. PubMed ID: 7490272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WA8242A1, A2 and B, novel secretory phospholipase A2 inhibitors produced by Streptomyces violaceusniger. I. Taxonomy, production and purification.
    Yoshimura S; Otsuka T; Tsurumi Y; Muramatsu Y; Hatanaka H; Okamoto M; Hashimoto S; Okuhara M
    J Antibiot (Tokyo); 1998 Jan; 51(1):1-7. PubMed ID: 9531980
    [No Abstract]   [Full Text] [Related]  

  • 40. Novel delta2-isoxazolines as group II phospholipase A2 inhibitors.
    Basappa ; Satish Kumar M; Nanjunda Swamy S; Mahendra M; Shashidhara Prasad J; Viswanath BS; Rangappa KS
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3679-81. PubMed ID: 15203142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.